Benchmark Maintains Buy on Staar Surgical, Lowers Price Target to $50

Benchmark maintains Staar Surgical (NASDAQ:STAA) with a Buy and lowers the price target from $54 to $50.

Benzinga · 11/19/2019 12:57

Benchmark maintains Staar Surgical (NASDAQ:STAA) with a Buy and lowers the price target from $54 to $50.